P
PepGen Inc. (PEPG)
NMS – Real Time Price. Currency in USD
1.68
-0.02 (-1.18%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.68
-0.02 (-1.18%)
At close: May 12, 2026, 4:00 PM EDT
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Hayley Parker Ph.D. | Senior Vice President of Global Regulatory Affairs & Quality |
| Dr. James G. McArthur Ph.D. | President, CEO, Treasurer, Secretary & Director |
| Dr. Kasra Kasraian Ph.D. | Chief Technical Officer |
| Dr. Paul D. Streck M.B.A., M.D. | Executive VP and Head of Research & Development |
| Mr. Gregory Song | Executive Director & Head of Biometrics |
| Mr. Joseph D. Vittiglio Esq., J.D. | Chief Business & Legal Officer and Secretary |
| Mr. Noel P. Donnelly M.B.A. | Chief Financial Officer |
| Ms. Emiko Bryant | Senior Vice President of HR & Administration |
| Ms. Melissa Michaels | Executive Director & Head of Regulatory Affairs CMC |
| Ms. Pallavi Lonkar Ph.D. | Vice President & Head of Preclinical |
| Date | Type | Document |
|---|---|---|
| 2026-04-28 | DEFA14A | defa14a_04.28.2026.htm |
| 2026-04-28 | DEF 14A | pepg-20260428.htm |
| 2026-03-30 | 8-K | pepg-20260330.htm |
| 2026-03-04 | S-8 | pepg-20260304.htm |
| 2026-03-04 | 8-K | pepg-20260304.htm |
| 2025-12-08 | 8-K | pepg-20251208.htm |
| 2025-11-12 | 10-Q | pepg-20250930.htm |
| 2025-11-07 | 8-K | pepg-20251104.htm |
| 2025-10-01 | 8-K | pepg-20251001.htm |
| 2025-09-26 | 8-K | d911432d8k.htm |